# Andre Crawford-Brunt

> Andre Crawford-Brunt is a Series A investor at Braavos Investment Advisers backing Medical. See 4 investments, round sizes, portfolio and contact details…

- Type: Angel Investor
- Firm: Braavos Investment Advisers
- Location: London, United Kingdom
- Total investments: 4
- Last investment: Feb 2021
- Lead investor: 25%
- Last updated: Nov 2026
- LinkedIn: https://www.linkedin.com/in/andre-crawford-brunt-7a9a0589

Andre Crawford-Brunt is a Series A investor at Braavos Investment Advisers in London focused on Medical and Software. Andre Crawford-Brunt

## Contacts

5 contacts available for Andre Crawford-Brunt: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/andre-crawford-brunt-562c?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $13M–$33M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 50% |
| Software | 2 | 50% |
| Smart Home | 1 | 25% |
| Health Care | 1 | 25% |
| Life Science | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Seed | 1 | 25% |
| Pre-Seed | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 3 | 75% |
| The Netherlands | 1 | 25% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SpyBiotech | SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centerswith a new and modified technology to develop vaccines which give better results in lesser time. | $32.5M | Series A | Feb 10, 2021 | http://spybiotech.com |
| PQShield | Formed as a spinout of the University of Oxford by cryptography researchers and specialists, PQShield has unrivalled domain expertise in the design and implementation of quantum-resistant cryptography for software and hardware applications. PQShield is a major contributing participant to the National Institute of Standards and Technology (NIST)Post-Quantum Standardisation Process. At PQShield, we help customers transition their product lines from legacy RSA and Elliptic Curve cryptography to quantum-secure standards by offering ready-made and tailored IP for secure elements, IoT firmware, PKI and server technologies, and end-user applications." | $6.9M | Seed | Jul 08, 2020 | https://pqshield.com/ |
| DeNoize | DeNoize is a smart window technology that transforms any glass facade into a noise-canceling system. | $98K | Pre-Seed | Oct 05, 2018 | https://denoize.com/ |
| Ultromics | Ultromics develops AI-powered software solutions to assist in cardiovascular disease diagnosis through echocardiography. The company provides platforms that support clinicians in interpreting echocardiogram data by applying machine learning to detect patterns and abnormalities that may indicate heart conditions. Ultromics offers its flagshipproduct, EchoGo, which automates the analysis of echocardiograms and delivers quantitative reports on cardiac function and structure. The software integrates with existing clinical workflows and is designed to enhance decision-making consistency while reducing variability in scan interpretation. Ultromics focuses on leveraging data-driven approaches to support early detection of conditions such as heart failure and coronary artery disease. Its technology is built on research collaborations and large-scale clinical datasets, aiming to improve diagnostic outcomes and support clinical efficiency. | $13.4M | Series A | May 22, 2018 | http://www.ultromics.com/ |

4 of 4 investments shown.

## Co-investors
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-science-enterprises) — VC Fund, 3 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 3 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 2 deals together
- [Crane Venture Partners](https://shizune.co/investors/profile/crane-venture-partners) — VC Fund, 1 deal together
- [Deep Science Ventures](https://shizune.co/investors/profile/deep-science-ventures) — VC Fund, 1 deal together
- [Fushia Investments](https://shizune.co/investors/profile/fushia-investments) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [SOSV SF & NY (Fka IndieBio)](https://shizune.co/investors/profile/synbio-axlr8r) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund
- [Seedcamp](https://shizune.co/investors/profile/seedcamp) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in United Kingdom](https://shizune.co/investors/medical-angel-investors-united-kingdom)

## FAQ

### What does Andre Crawford-Brunt invest in?

Andre Crawford-Brunt invests primarily in Medical, Software and Smart Home startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What round sizes does Andre Crawford-Brunt invest in?

Andre Crawford-Brunt typically joins rounds of $13M–$33M at Series A. These are whole funding-round sizes, not Andre Crawford-Brunt's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Andre Crawford-Brunt took part in.

### How do I contact Andre Crawford-Brunt?

Public channels for Andre Crawford-Brunt include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Andre Crawford-Brunt last invest?

The most recent investment recorded for Andre Crawford-Brunt closed in Feb 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co